Search / Trial NCT06228131

Detection of hCG in Early Pregnancy Clinical Samples

Launched by ANDON HEALTH CO., LTD · Jan 19, 2024

Trial Information

Current as of December 22, 2024

Completed

Keywords

ClinConnect Summary

No description provided

Gender

FEMALE

Eligibility criteria

  • Inclusion Criteria:
  • Female;
  • 18-55 years of age;
  • In a state of preparing for pregnancy;
  • Voluntary and sign informed consent form.
  • Exclusion Criteria:
  • Within 8 weeks of childbirth or abortion;
  • The investigator has reason to believe that it is inappropriate for subjects to participate in the study.

About Andon Health Co., Ltd

Andon Health Co., Ltd. is a leading healthcare technology company dedicated to enhancing patient care through innovative medical devices and solutions. With a strong focus on research and development, Andon Health specializes in diagnostic equipment and telemedicine technologies that empower healthcare providers and improve patient outcomes. Committed to advancing medical science, the company actively sponsors clinical trials to validate the efficacy and safety of its products, fostering a collaborative approach to healthcare advancement. Through its rigorous clinical research initiatives, Andon Health aims to contribute to the global healthcare landscape by delivering reliable, cutting-edge solutions that meet the evolving needs of patients and clinicians alike.

Locations

Tianjin, , China

Tianjin, , China

People applied

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Discussion 0